Saudi Deputy Minister of Hajj: Full Return of Pilgrim Numbers to Pre-Pandemic Levels

Saudi Arabia’s Deputy Minister of Hajj and Umrah Abdulfattah Mashat (Asharq Al-Awsat)
Saudi Arabia’s Deputy Minister of Hajj and Umrah Abdulfattah Mashat (Asharq Al-Awsat)
TT

Saudi Deputy Minister of Hajj: Full Return of Pilgrim Numbers to Pre-Pandemic Levels

Saudi Arabia’s Deputy Minister of Hajj and Umrah Abdulfattah Mashat (Asharq Al-Awsat)
Saudi Arabia’s Deputy Minister of Hajj and Umrah Abdulfattah Mashat (Asharq Al-Awsat)

Saudi Arabia’s Deputy Minister of Hajj and Umrah Abdulfattah Mashat affirmed that the ministry has used the same process as before the coronavirus pandemic to decide how many pilgrims will be allowed from each country.

The goal is to bring back the number of pilgrims to what it was before the pandemic. He also stressed that this season is special and that all the necessary services are ready at the holy sites.

Mashat, in an interview with Asharq Al-Awsat, confirmed the existence of precautionary plans to handle any health or organizational emergencies that might occur this Hajj season.

These plans are a part of Saudi Arabia’s ability to manage crowds and handle important information.

The deputy minister also disclosed that relevant authorities in the Kingdom have received many requests to participate in the “Makkah Route Initiative,” and these requests are currently under review by the Interior Ministry.

Regarding company classification, Mashat stated that this year, the categorization of service providers will be based on customer satisfaction using evaluation forms that have been developed on one of the important post-Hajj platforms.

He pointed out that opportunities have been given to several leading hospitality companies to offer their competitive services.

Mashat emphasized that companies that fall short will be held accountable, and that there are mechanisms in place to compensate pilgrims for any shortcomings they may experience.

The deputy minister asserted that this year’s Hajj season is different.

Early readiness was ensured for all services, as well as integration, coordination, and harmony among all the plans of the participating entities in the Hajj process.

According to Mashat, there is significant collaboration between the Ministry of Hajj and Umrah and all relevant authorities, working together to develop a coordinated working plan through the bureau of operational follow-up and the Central Hajj Committee.

The Committee is responsible for continuous monitoring of all Hajj-related operational activities.

Mashat clarified that early preparation is a crucial part of the organization process, in line with the Ministry of Hajj's strategy. This was evident in the various services offered to both domestic and international pilgrims.

Domestic pilgrims had access to all packages through a local platform, while international pilgrims from Europe, America, Australia, and Canada were able to access the “Nusuk Hajj” platform online in advance.

Mashat also described the Nusuk Hajj platform as one of the most important programs aimed at pilgrims from Europe, America, and Australia. Launched several months ago, the platform has facilitated the issuance of over 20,000 visas for prospect pilgrims.

In a conversation about what sets apart the Hajj season 2023 from previous years, Mashat emphasized a remarkable highlight: the triumphant comeback of pilgrim numbers to their pre-pandemic levels.

While the deputy minister did not directly disclose the exact number, statistics from the General Authority for Statistics (GASTAT) estimate that the number of pilgrims in the year 2019 exceeded 2.4 million.

At that time, the number of domestic pilgrims was approximately 634,000, including around 211,000 Saudi pilgrims and about 423,000 residents of the Kingdom with valid permits.

Regarding the Makkah Route Initiative and its significance, Mashat said: “We have received numerous requests from several countries to join the initiative, and the specialized committee, led by the Ministry of Interior, is thoroughly studying all of these requests.”

Mashat also discussed epidemics and how to deal with them.

“With the end of the (coronavirus) pandemic, there are proactive and preventive precautionary plans in place to handle any health or organizational emergencies that may arise during this season,” he told Asharq Al-Awsat.

Mashat stressed that Saudi Arabia’s extensive experience has led to the creation of exceptional crowd management models.

The Kingdom has the ability to tackle any scenario, making its approach unparalleled worldwide.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.